Tearsoft

Quick links to important sections

Tearsoft

Method of action: Ophthalmologicals

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tearsoft

What is Tearsoft?

Tearsoft is an ophthalmic solution formulated as an artificial tear to provide relief from ocular dryness and discomfort. It is designed to mimic the properties of natural human tears, helping to maintain the hydration of the ocular surface and protect the eye from environmental irritants.

Composition and Mechanism

The solution typically contains lubricating agents such as carboxymethylcellulose or similar polymers that increase the viscosity of the tear film. This helps the solution remain on the surface of the eye for a longer duration, providing a protective barrier and reducing friction during blinking.

Primary Uses

Tearsoft is used to manage symptoms associated with dry eye syndrome and other conditions that lead to insufficient tear production or poor tear quality. Common indications include:

  • Relief of burning, irritation, and discomfort caused by dry eyes.
  • Protection against further irritation from wind, sun, or heating and air conditioning.
  • Management of eye strain resulting from prolonged computer use or reading.

By supplementing the natural tear film, the solution helps to stabilize the moisture balance on the cornea and conjunctiva, contributing to improved visual comfort and clarity.

What side effects are possible with Tearsoft?

The safety profile of Tearsoft (Carmellose) is defined by its classification as an ophthalmic demulcent with negligible systemic exposure, as documented in government regulatory sources. Adverse reactions are primarily localized to the ocular system and are formally categorized by frequency.

Officially Documented Adverse Reactions

Adverse reactions are mainly associated with the Eye disorders System-Organ Class (SOC):

Classification Examples of Officially Listed Effects
Common Eye irritation (including burning), Eye pain, Eye pruritus, Visual disturbance.
Frequency Not Known Blurred vision, Ocular hyperemia (redness), Hypersensitivity (including eye allergy), Superficial injury of eye, Corneal abrasion.

Serious Safety Indicators and Constraints

The official label highlights specific symptoms that act as serious safety indicators requiring assessment, including changes in vision, persistent eye pain, or continued redness/irritation. The blurring of vision is noted as a transient (short-term) safety pattern following application.

Population-Specific Safety: The drug's safety profile permits its use during pregnancy and breast-feeding due to its negligible systemic absorption. Safety and efficacy in the paediatric population are supported by clinical experience.

Safety Restrictions: The label mandates the solution not be used if it changes color or becomes cloudy, which is a critical constraint for maintaining product sterility. There is also a documented risk of displacement or alteration of other concomitantly administered ocular medications.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information for Tearsoft (Carmellose) indicates that the potential for a hazardous overdose is extremely low. This is consistent with its classification as an ophthalmic demulcent, which is not significantly absorbed into the body when applied to the eye, resulting in negligible systemic exposure.


Official Regulatory Position on Overdose

Classification Documentation Summary
Documented Manifestations None listed for ocular over-administration. Regulatory documents state accidental overdose “will present no hazard.”
Severe Outcomes None documented or expected due to minimal systemic absorption.
Urgent Help Required Not mandated for accidental ocular overdose, as no hazard is presented.

Management and Emergency Response

The official overdose profile is characterized by the absence of documented risk from ocular over-administration. As a result, there are no specific emergency actions required or mandated by regulatory authorities following the use of too much of the eye drop solution.

In the unlikely event of accidental oral ingestion (swallowing the solution), the officially recommended procedural instruction is the application of symptomatic therapy. This guidance reflects a general safety measure rather than a response to a specific systemic toxicity risk, supporting the overall profile of low hazard.

Therapeutic Uses of Tearsoft

Quick Facts

  • Tearsoft is utilized for the temporary relief of discomfort associated with dryness of the eye.
  • Its application helps to manage symptoms like burning and irritation due to ocular dryness.
  • The therapeutic objective is to support ocular lubrication and moisture on the eye surface.

Tearsoft is a prescription or over-the-counter formulation indicated for addressing symptoms related to dry eyes. The primary purpose of this product is to provide temporary alleviation of discomfort, burning, and irritation that may result from insufficient tear production or exposure to environmental factors.

Therapeutic application functions to supplement the eye's natural tear film. Maintaining appropriate surface moisture and lubrication may help reduce the feeling of grittiness and soreness. Tearsoft provides a mechanism to support the integrity of the ocular surface when affected by dryness. The overall benefit is related to supporting eye comfort by aiding in surface hydration and lubrication. This medication is part of a management strategy for situational or chronic ocular dryness.

Regulatory References

  1. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2ef16864-97cb-4dfe-9461-cba156144c69&audience=consumer

Eligibility and Restrictions for Use

Who Can and Cannot Use Tearsoft? (Official Regulatory Information)

The population eligibility for Tearsoft (Carmellose ophthalmic solution) is primarily determined by local sensitivity and specific age-group data documented in regulatory labels.

Populations That Must Not Use (Contraindication)

  • Hypersensitivity: The medicine is contraindicated for any individual with a known allergy or hypersensitivity to the active ingredient, Carmellose sodium, or to any of the product's inactive ingredients (excipients), as specified in the official label.

Age-Related Eligibility

Age Group Regulatory Status Constraint Context
Adults & Older Adults Permitted Standard use with no maximum age restriction or dose adjustment required.
Pediatric Population Conditional / Not Established Safety and efficacy in children and adolescents are sometimes not established by formal trial data, leading some labels to state use is not recommended.

Special Condition Eligibility

Due to the negligible systemic absorption of Carmellose:

  • Pregnancy and Breastfeeding: Use is permitted during both conditions, as regulatory documents confirm the active substance is unlikely to pose a risk.
  • Systemic Conditions: There are no official restrictions or specific dosage adjustments documented for patients with hepatic impairment or renal impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Tearsoft contains Carmellose (Carboxymethylcellulose), an ophthalmic demulcent. The official regulatory profile for this product is defined by its local application and negligible systemic absorption, meaning that conventional pharmacological drug-drug interactions are neither anticipated nor documented.

Systemic and Metabolic Interactions

Official regulatory labels confirm that due to the lack of systemic exposure, there are no known interactions with medicinal products that act via metabolic enzymes (such as the CYP system), drug transporters, or other systemic pathways. This also extends to the absence of documented interactions with food, alcohol, or herbal products.

Local Ocular Interaction and Administration

The most significant interaction is a local physical one with other topically applied eye preparations. Since Tearsoft is designed to coat the eye surface, it can physically interfere with the absorption or contact time of concurrently administered eye drops or eye ointments.

Constraint Interacting Product Category Requirement in Regulatory Labeling
Timing-based Rule Other Ocular Medications Must be administered at least 15 minutes apart from Tearsoft.

No contraindicated combinations are listed based on interaction risk, and no population-specific interaction cautions (e.g., for liver impairment) are noted in the official prescribing information.

Mechanism of Action

How Tearsoft Works: Mechanism of Action

Tearsoft acts by engaging specific biological targets to modulate signaling within defined pathways.

Targeted Engagement of the [Specific Receptor/Enzyme] System

Tearsoft exerts its effect by initiating a precise interaction, serving as an [Agonist/Antagonist/Inhibitor] at the [Name of Receptor/Enzyme] site. This primary mechanistic focus on a single biological target influences the input signal and subsequent activity of the defined pathway.

Modulation of Downstream Signaling Cascades

Following target engagement, Tearsoft modifies the entire signal transduction cascade, influencing mediators and transmitters downstream of the primary target. This mechanistic activity dampens or suppresses the signaling sequences, modulating the level of pathway activation in affected tissues.

Altering Systemic Pathway Activity

Modification of these key molecular steps alters the characteristics of pathway activity. This pathway adjustment alters the level of mediator activity within the system, contributing to the overall effect profile through mechanistic action.

Dosage and Administration Information

Administration Method

Tearsoft is designed for topical application to the eye. Proper administration ensures that the solution is distributed evenly across the ocular surface.

Preparation

Before application, it is important to wash hands thoroughly with soap and water. If the solution appears cloudy or contains particles, it should not be used. For those wearing contact lenses, the lenses should generally be removed prior to application unless otherwise specified by a healthcare professional.

Application Steps

  1. Tilt the head back slightly and look upward.
  2. Gently pull down the lower eyelid to create a small pocket.
  3. Hold the dropper bottle above the eye, ensuring the tip does not touch the eye, eyelashes, or any other surface to maintain sterility.
  4. Squeeze the bottle gently to release the required amount of solution into the eyelid pocket.
  5. Close the eye gently. To assist with absorption and prevent the liquid from draining into the tear duct, light pressure can be applied to the inner corner of the eye (near the nose) for one to two minutes.
  6. If the solution is being used in both eyes, repeat the process for the second eye.

Handling and Storage

To prevent contamination, the dropper tip should never come into contact with any surface. The cap should be replaced tightly immediately after each use. Store the container at room temperature, away from direct light and moisture, and keep it out of reach of children. Discard any remaining solution after the timeframe recommended on the packaging following the initial opening.

Recent Clinical Evidence

Research Exploring Dry Eye Disease (DED)

The evidence base for Carmellose was developed in research exploring conditions characterized by fluctuating or episodic manifestations of dryness, burning, and irritation. Randomized Controlled Trials (RCTs), a research method used to evaluate outcomes, have been used to examine Carmellose, often comparing it against an inactive substance (placebo) or other commercially available tear substitutes.

These studies were applied in research contexts involving fluctuating or unstable symptoms. Researchers examined outcomes related to physical discomfort, monitoring how patients reported their experiences using standardized questionnaires such as the Ocular Surface Disease Index (OSDI). They also monitored objective outcomes related to eye health by using objective markers, such as the Tear Break-Up Time (TBUT), a measurement of tear film integrity, and staining scores, which check for physical markers on the eye's surface. Studies monitored how outcomes evolved during the observation period.

Research on Situational and Post-Procedure Dryness

Research has also explored Carmellose in specific scenarios. Observational studies and subgroup analyses have focused on conditions where symptoms may vary in intensity, such as dryness associated with prolonged use of visual display terminals (computer screens). Carmellose was also evaluated in patients experiencing dry eye symptoms following certain ocular procedures or surgery. This evidence contributes to understanding symptom patterns in populations dealing with conditions associated with acute or disruptive episodes of dryness.


Research on Outcomes and Comparison to Other Treatments

When studies explored short-term symptom changes and compared Carmellose formulations to other widely used polymeric tear substitutes, findings were mixed. Some systematic reviews that evaluated multiple trials indicated that statistical differences between Carmellose and other lubricant ingredients were not consistently established across all measured outcomes. This evidence contributes to the broader evidence landscape by helping contextualize how patients reported their experience when compared to alternatives.


What is Still Uncertain About Tearsoft Research

One key limitation is the variability in formulations studied. Trials sometimes used different concentrations of the active ingredient or different preservative systems, which may influence the results, making it difficult to draw broad conclusions. Furthermore, comparative evidence is lacking when attempting to establish a definitive hierarchy of patterns across all common lubricant eye drops. Evidence quality varies across studies, and while numerous RCTs exist, subgroup findings are uncertain, meaning the research does not provide a prediction of whether an individual will respond similarly to the group patterns observed.

Key Studies & References

  1. Dry eye (keratoconjunctivitis sicca, KCS) - Clinical Management Guideline
  2. Assessing the Effects of 0.3% Carboxymethylcellulose Tear Substitute Treatment on Symptoms and Signs of Dry Eye Disease in Elderly Population: A Prospective Longitudinal Study

Frequently Asked Questions (FAQ)

Common questions about Tearsoft (FAQ)


Q: How quickly does Tearsoft typically start relieving dry eye symptoms?

A: Tearsoft is classified as an ophthalmic demulcent, which functions to provide temporary relief from the symptoms of dry eyes, such as burning or irritation. This indication for 'temporary relief' indicates the drops are intended to provide comfort upon application.


Q: How long do the lubricating effects of Tearsoft usually last after one application?

A: Official information indicates that the product provides temporary relief. If the dry eye condition persists or worsens for more than 72 hours, official guidance suggests consulting a healthcare professional.


Q: Is Tearsoft effective for eye dryness caused by wind, air conditioning, or sun exposure?

A: Yes, regulatory documents indicate that the product is intended for the temporary relief of discomfort caused by dryness of the eye due to exposure to environmental factors, including wind or sun. The lubricating action is intended to soothe the eye surface discomfort caused by these external factors.


Q: Does Tearsoft treat the underlying cause of dry eyes, or only the symptoms?

A: Tearsoft is categorized as an Eye Lubricant and is used for the temporary relief of dry eye symptoms. It functions as a tear substitute to physically lubricate the eye surface and is not intended to treat the underlying causes of dry eye disease.


Q: What is the purpose of the preservative in Tearsoft, or is it preservative-free?

A: In multi-dose bottles, a preservative is used to maintain the sterility of the solution and help prevent contamination after opening. Furthermore, many products in this class are also available in specially packaged preservative-free options for users who prefer formulations without preservatives.


Q: Is it safe to use Tearsoft if I have a history of glaucoma or cataracts?

A: The official label advises that if new or worsening symptoms like eye pain or changes in vision occur, the user should discontinue use immediately. Official guidance is to discontinue use and consult a healthcare professional immediately if these symptoms occur. Some official labels specify that if a patient has a condition such as narrow-angle glaucoma, medical advice should be sought prior to use.


Q: Why do instructions advise against touching the dropper tip of Tearsoft to the eye or any surface?

A: Regulatory warnings emphasize that touching the dropper tip to the eye, eyelid, or any other surface must be avoided. This is a critical step necessary to prevent the solution from becoming contaminated with germs or other foreign matter.


Q: Are there any known interactions between Tearsoft and other medicated eye drops (e.g., glaucoma drops)?

A: The primary interaction is physical and localized to the eye surface, as Tearsoft coats the eye. To ensure that other medicated eye drops are properly absorbed, regulatory documents specify that they must be administered at least 15 minutes apart from Tearsoft.


Q: Can Tearsoft be used after certain eye procedures, such as LASIK surgery?

A: In instances where the product is used for post-operative dryness or discomfort (e.g., following a procedure like LASIK), the official label specifies that this use must be conducted under the guidance of an eye doctor.


Q: Is Tearsoft suitable for use by individuals with sensitive eyes?

A: Official warnings state that the product must not be used if you are sensitive or allergic to the active ingredient (Carmellose) or any other component. This is due to the potential risk of an allergic reaction or worsening irritation.


Q: Can Tearsoft help with the feeling of having something gritty or sandy in the eye?

A: The product is officially indicated for the temporary relief of burning, irritation, and discomfort due to eye dryness. These indications for temporary relief of irritation cover the type of discomfort often described as a sandy or gritty feeling in the eye.


Q: Is Tearsoft available over-the-counter, or is a prescription generally required?

A: Tearsoft is classified in the United States as a HUMAN OTC DRUG (Over-The-Counter). This designation means it is generally available for purchase without the need for a prescription from a doctor.


Q: What are the long-term safety data available for the active ingredient in Tearsoft?

A: Official regulatory information manages long-term use by advising users to consult a doctor if the dry eye condition persists or worsens for more than 72 hours. This guidance is in place to ensure ongoing safety and appropriate management of the underlying condition.


Q: Does the use of Tearsoft require any specific precautions before driving or operating machinery?

A: Official product information confirms there may be a possibility of transient blurred vision immediately following application. Due to this potential effect, official guidance is to wait until vision clears before attempting tasks such as driving or operating machinery.


Q: What does it mean that Tearsoft is considered a 'lubricant' or 'tear substitute'?

A: This classification is based on the product’s function as an Eye Lubricant and Eye Protectant. It works by temporarily replacing or supplementing your natural tear film to provide a protective layer of moisture on the ocular surface and relieve dryness symptoms.


How should Tearsoft be stored and disposed of?

Storage and Disposal of Tearsoft

The storage and disposal instructions for Tearsoft (Carboxymethylcellulose ophthalmic solution) are critical for maintaining the product's sterility and effectiveness, as mandated by regulatory documents.

Official Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, typically between 15 C and 30 C (59 F and 86 F).
Container Keep out of reach of children and store in the original carton. Avoid touching the container tip to any surface.
Stability (Single-Use) The vial must be used immediately after opening and discarded; reuse is strictly prohibited.

Disposal

Any opened single-use container must be discarded immediately after use. Unused or expired medication, or any waste material, should be disposed of in accordance with local requirements for medicinal products.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tearsoft found in:

A-Z Index: